Multimodality Risk Adapted Tx Including Induction Chemo for SCCHN Amenable to Transoral Surgery
UNC Lineberger Comprehensive Cancer Center
UNC Lineberger Comprehensive Cancer Center
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
M.D. Anderson Cancer Center
UNC Lineberger Comprehensive Cancer Center
Massachusetts General Hospital
UNC Lineberger Comprehensive Cancer Center
H. Lee Moffitt Cancer Center and Research Institute
M.D. Anderson Cancer Center
University of Kentucky
Sanford Health
Dana-Farber Cancer Institute
University of Pittsburgh
Memorial Sloan Kettering Cancer Center
University of Chicago
University of Alabama at Birmingham
Case Comprehensive Cancer Center
University of Pittsburgh
Grupo Español de Tratamiento de Tumores de Cabeza y Cuello
UNC Lineberger Comprehensive Cancer Center
EpicentRx, Inc.
UNC Lineberger Comprehensive Cancer Center
University of Pittsburgh
University of Oxford
University College, London
UNC Lineberger Comprehensive Cancer Center
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
H. Lee Moffitt Cancer Center and Research Institute
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Boston Scientific Corporation
University of Texas Southwestern Medical Center
Hunan Cancer Hospital
University Health Network, Toronto
Sun Yat-sen University
University of Texas Southwestern Medical Center
University of Chicago
National Institutes of Health Clinical Center (CC)
Tianjin Medical University Cancer Institute and Hospital
Daiichi Sankyo
Amgen
Russian Academy of Medical Sciences
Ohio State University Comprehensive Cancer Center
University of Pittsburgh
Emory University
Amgen
Jiangsu Simcere Pharmaceutical Co., Ltd.
HealthCare Global Enterprise Ltd.
Japan Clinical Oncology Group
Shanghai Chest Hospital
Sanofi
British Columbia Cancer Agency